[MO36] Mini-Oral Session 36　Palliative Care / Symptom Management 2

[MO36-6] Phase II randomized study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea (MERMAID) WJOG11318B

^○Yuko Tanabe¹, Hiroko Masuda², Koji Matsumoto³, Akihiko Shimomura⁴, Mihoko Doi⁵, Yasuo Miyoshi⁶, Masato Takahashi⁷, Yasuaki Sagara⁸, Shinya Tokunaga⁹, Tsutomu Iwasa¹⁰, Naoki Niikura¹¹, Kenichi Yoshimura¹³, Toshimi Takano¹⁴, Junji Tsurutani¹⁴ (1.Department of Medical Oncology, Toranomon Hospital, 2.Department of Breast Surgical Oncology, Showa University, 3.Medical Oncology Division, Hyogo Cancer Center, 4.Department of Breast and Medical Oncology, 5.Division of Clinical Oncology, Hiroshima Prefectural Hospital, 6.Division of Breast and Endocrine, Department of Surgery, Cancer Center, Hyogo College of Medicine, 7.Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, 8.Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, 9.Department of Medical Oncology, Osaka City General Hospital, 10.Department of Medical Oncology, Kindai University Hospital, 11.Department of Breast Oncology, Tokai University School of Medicine, 12.Center for Integrated Medical Research, Hiroshima University, 13.Department of Breast Medical Oncology The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 14.Advanced Cancer Translational Research Institute, Showa University)